0001209191-18-055188.txt : 20181016 0001209191-18-055188.hdr.sgml : 20181016 20181016182813 ACCESSION NUMBER: 0001209191-18-055188 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181012 FILED AS OF DATE: 20181016 DATE AS OF CHANGE: 20181016 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zhang Eric CENTRAL INDEX KEY: 0001753274 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36361 FILM NUMBER: 181125171 MAIL ADDRESS: STREET 1: C/O VERSARTIS, INC. STREET 2: 1020 MARSH ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aravive, Inc. CENTRAL INDEX KEY: 0001513818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264106690 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LYONDELLBASELL TOWER STREET 2: 1221 MCKINNEY STREET, SUITE 3200 CITY: HOUSTON STATE: TX ZIP: 77010 BUSINESS PHONE: 936-355-1910 MAIL ADDRESS: STREET 1: LYONDELLBASELL TOWER STREET 2: 1221 MCKINNEY STREET, SUITE 3200 CITY: HOUSTON STATE: TX ZIP: 77010 FORMER COMPANY: FORMER CONFORMED NAME: Versartis, Inc. DATE OF NAME CHANGE: 20110223 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-12 0 0001513818 Aravive, Inc. ARAV 0001753274 Zhang Eric C/O ARAVIVE, INC. LYONDELLBASEL TOWER, 1221 MCKINNEY ST. HOUSTON TX 77010 1 0 0 0 Common Stock 2018-10-12 4 A 0 859766 A 859766 I See footnote Shares of common stock of the corporation known as Aravive Biologics, Inc. ("Aravive") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of June 3, 2018, by and among the Issuer, Velo Merger Sub, Inc. and Aravive (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of Aravive common stock was exchanged for 2.2801 shares of the Issuer's common stock. Following the merger, the Issuer effected a reverse stock split at a ratio of one share for every six shares of Issuer common stock and the Issuer changed its name to Aravive, Inc. All share numbers reflect the reverse stock split. Shares of common stock of the Issuer held by Elite Vantage Global Limited. The Reporting Person is a director of Elite Vantage Global Limited. The address for Elite Vantage Global Limited is Suite 1807, 18F, China Resources Building, 26 Harbor Road, Hong Kong. The Reporting Person disclaims beneficial ownership of the shares held by Elite Vantage Global Limited except to the extent of his pecuniary interest therein. /s/ Kevin Haas, Attorney-in-fact 2018-10-16